Amy E. Tapper - 08 Nov 2022 Form 4 Insider Report for Imago BioSciences, Inc.

Reporting relationship: Chief, Technical Operations
Issuer ticker: N/A
Reported as of: 08 Nov 2022
Net transaction value: $0
SEC form: 4
Accepted by SEC: 14 Nov 2022, 17:57:23 UTC
Prior SEC filing: 04 Nov 2022
Next SEC filing: 20 Dec 2022
Source filing: View source filing
Reporting owner signature: /s/ Hugh Y. Rienhoff, Jr., M.D., as Attorney-in-Fact for Amy E. Tapper

Key filing fact

Amy E. Tapper filed Form 4 for Imago BioSciences, Inc. on 14 Nov 2022.

Key facts

This page summarizes Amy E. Tapper's Form 4 filing for Imago BioSciences, Inc..
1 reported transaction and 1 derivative row are listed below.
Accepted by SEC: 14 Nov 2022, 17:57.

Change

Previous filing in this sequence was filed on 04 Nov 2022.
Current net transaction value: $0.

Research use

This tells you what this filing adds before you inspect full transaction and derivative tables.
You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reported derivative securities

Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.

IMGO transaction Derivative

Stock Option (Right to Buy)

Award

Transaction value: $0
Shares: +103,000
Change %
Price: $0.000000
Shares after: 103,000
Date: 08 Nov 2022
Ownership: Direct
Underlying class: Common Stock
Underlying amount: 103,000
Exercise price: $15.45
Footnotes: F1

^* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 1 footnote

Footnote F1

One forty-eighth (1/48th) of the shares initially subject to the option will vest on each monthly anniversary measured from November 8, 2022 (the "Vesting Commencement Date"), so that 100% of the shares subject to the option will be fully vested and exercisable as of the fourth anniversary of the Vesting Commencement Date, subject to the Reporting Person's continued service through each vesting date.

SEC remarks

Chief, Technical Operations